Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01439594 · ClinicalTrials.gov registry record · NA
Optical Frequency Domain Imaging (OFDI) Assessment in Radiofrequency Ablation
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01439594: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01439594 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01439594, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The goal of this research is to conduct a pilot clinical study to evaluate the potential use of esophageal Optical Frequency Domain Imaging (OFDI) for assessing the success and degree of injury associated with therapeutic radiofrequency ablation techniques.
Interventions
- DEVICE MGH OFDI Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-10 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01439594
The ClinicalTrials.gov registry entry for NCT01439594 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MGH OFDI Imaging is the first listed.
NCT01439594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01439594 about?
NCT01439594 is a clinical study titled "Optical Frequency Domain Imaging (OFDI) Assessment in Radiofrequency Ablation". The goal of this research is to conduct a pilot clinical study to evaluate the potential use of esophageal Optical Frequency Domain Imaging (OFDI) for assessing the success and degree of injury associated with therapeutic radiofrequency ablation techniques.
What is the current status of trial NCT01439594?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2008-10. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01439594?
The interventions under investigation include: MGH OFDI Imaging (DEVICE).
Who is sponsoring clinical trial NCT01439594?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.